Gene · 2823
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recruitment of the m6A/m6Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48. | Genome Biol | 2024 | 39300486 | PubTator, text mining | PubMed |
| Regulatory effect of N6-methyladenosine on tumor angiogenesis. | Front Immunol | 2024 | 39295872 | PubTator, text mining | PubMed |
| The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy. | Cell Death Dis | 2024 | 39294131 | PubTator, text mining | PubMed |
| Molecular mechanism of ALKBH5-mediated m6A demethylation regulating lipopolysaccharide-induced epithelial-mesenchymal transition in sepsis-induced acute kidney injury. | Kaohsiung J Med Sci | 2024 | 39287046 | PubTator, text mining | PubMed |
| Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL. | Front Pharmacol | 2024 | 39281280 | PubTator, text mining | PubMed |
| POP1 Facilitates Proliferation in Triple-Negative Breast Cancer via m6A-Dependent Degradation of CDKN1A mRNA. | Research (Wash D C) | 2024 | 39268503 | PubTator, text mining | PubMed |
| The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis. | Front Cell Dev Biol | 2024 | 39220683 | PubTator, text mining | PubMed |
| FAM136A as a Diagnostic Biomarker in Esophageal Cancer: Insights into Immune Infiltration, m6A Modification, Alternative Splicing, Cuproptosis, and the ceRNA Network. | Adv Biol (Weinh) | 2024 | 39185769 | PubTator, text mining | PubMed |
| The RNA N6-methyladenosine demethylase FTO regulates ATG5 to inhibit malignant progression of uveal melanoma. | J Proteomics | 2024 | 39181531 | PubTator, text mining | PubMed |
| Research progress on m6A demethylase FTO and its role in gynecological tumors. | Front Oncol | 2024 | 39175477 | PubTator, text mining | PubMed |
| FTO-mediated m 6A demethylation of ULK1 mRNA promotes autophagy and activation of hepatic stellate cells in liver fibrosis. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39175431 | PubTator, text mining | PubMed |
| ALKBH5 governs human endoderm fate by regulating the DKK1/4-mediated Wnt/β-catenin activation. | Nucleic Acids Res | 2024 | 39166492 | PubTator, text mining | PubMed |
| YTHDF1 mediates translational control by m6A mRNA methylation in adaptation to environmental challenges. | bioRxiv | 2024 | 39149343 | PubTator, text mining | PubMed |
| Bulk serum extracellular vesicles from stressed mice show a distinct proteome and induce behavioral and molecular changes in naive mice. | PLoS One | 2024 | 39146369 | PubTator, text mining | PubMed |
| A novel m6A/m5C/m1A/m7G-related classification and risk signature predicts prognosis and reveals immunotherapy inclination in gastric cancer. | Transl Cancer Res | 2024 | 39145046 | PubTator, text mining | PubMed |
| Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors. | J Nat Prod | 2024 | 39136667 | PubTator, text mining | PubMed |
| A prognostic signature based on genes associated with m6A/m5C/m1A/m7G modifications and its immunological characteristics in clear cell renal cell carcinoma. | Sci Rep | 2024 | 39134681 | PubTator, text mining | PubMed |
| Effects of Naphtho[2,1-a]pyrene Exposure on CYP1A1 Expression: An in Vivo and in Vitro Mechanistic Study Exploring the Role of m6A Posttranscriptional Modification. | Environ Health Perspect | 2024 | 39133094 | PubTator, text mining | PubMed |
| The role of the ALKBH5 RNA demethylase in invasive breast cancer. | Discov Oncol | 2024 | 39127986 | PubTator, text mining | PubMed |
| Research Progress on the Role of M6A in Regulating Economic Traits in Livestock. | Int J Mol Sci | 2024 | 39125935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2823/papers?page=10